semaglutide dr reddy's Q&A: Dr. CEO on Generic and the GLP-1 Market Ahead Dr Reddy's, Sun, Zydus ready

We then plotted the cumulative medication cost over time against the flat cost of each surgery, thus calculating "break-even points" (when medication costs equal surgery costs)

GLP-1 receptor agonists are not indicated for type 1 diabetes and should not be used in patients with diabetic ketoacidosis

Semaglutide is internationally recognized for its ability to support significant weight loss and enhance overall health

The most common side effects of Mounjaro include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach (abdominal) pain

Always consult with a licensed clinician to ensure your treatment plan is tailored to your unique medical history, maximizing benefits while minimizing these potential complications